NIH plans funding for multidisciplinary tobacco regulatory science centers with at least three research projects to inform tobacco regulation and protect public health; clinical trials are optional.
FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
Funding available for testing innovative SBIRT/P methods for alcohol, tobacco, and drug use in adults with health disparities.
Funding opportunity for advancing nanotechnology-based cancer treatments to improve effectiveness through innovative nanoparticle designs and cargos.
This grant supports research to improve how cardiotoxicity from cancer treatments is detected, monitored, and treated, aiming to inform FDA regulatory decisions.
This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.